260 related articles for article (PubMed ID: 19426690)
21. Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells.
Mizuta K; Gallos G; Zhu D; Mizuta F; Goubaeva F; Xu D; Panettieri RA; Yang J; Emala CW
Am J Physiol Lung Cell Mol Physiol; 2008 Mar; 294(3):L523-34. PubMed ID: 18203813
[TBL] [Abstract][Full Text] [Related]
22. Investigating the effect of bilateral amygdala lesions on fear conditioning and social interaction in the male Mongolian gerbil.
Woolley ML; Haman M; Higgins GA; Ballard TM
Brain Res; 2006 Mar; 1078(1):151-8. PubMed ID: 16494851
[TBL] [Abstract][Full Text] [Related]
23. Two major groups of rat NKR-P1 receptors can be distinguished based on chromosomal localization, phylogenetic analysis and Clr ligand binding.
Kveberg L; Dai KZ; Westgaard IH; Daws MR; Fossum S; Naper C; Vaage JT
Eur J Immunol; 2009 Feb; 39(2):541-51. PubMed ID: 19130483
[TBL] [Abstract][Full Text] [Related]
24. Receptors and antagonists for substance P and related peptides.
Regoli D; Boudon A; Fauchére JL
Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
[No Abstract] [Full Text] [Related]
25. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
Aharony D; Buckner CK; Ellis JL; Ghanekar SV; Graham A; Kays JS; Little J; Meeker S; Miller SC; Undem BJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1216-21. PubMed ID: 7562491
[TBL] [Abstract][Full Text] [Related]
28. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
29. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.
Megens AA; Ashton D; Vermeire JC; Vermote PC; Hens KA; Hillen LC; Fransen JF; Mahieu M; Heylen L; Leysen JE; Jurzak MR; Janssens F
J Pharmacol Exp Ther; 2002 Aug; 302(2):696-709. PubMed ID: 12130734
[TBL] [Abstract][Full Text] [Related]
31. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
33. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
[TBL] [Abstract][Full Text] [Related]
34. Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment.
Pinto FM; Armesto CP; Magraner J; Trujillo M; Martín JD; Candenas ML
Endocrinology; 1999 Jun; 140(6):2526-32. PubMed ID: 10342838
[TBL] [Abstract][Full Text] [Related]
35. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.
Liu C; Wilson SJ; Kuei C; Lovenberg TW
J Pharmacol Exp Ther; 2001 Oct; 299(1):121-30. PubMed ID: 11561071
[TBL] [Abstract][Full Text] [Related]
36. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.
Boden P; Eden JM; Hodgson J; Horwell DC; Hughes J; McKnight AT; Lewthwaite RA; Pritchard MC; Raphy J; Meecham K; Ratcliffe GS; Suman-Chauhan N; Woodruff GN
J Med Chem; 1996 Apr; 39(8):1664-75. PubMed ID: 8648606
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
38. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
Geldenhuys WJ; Kuzenko SR; Simmons MA
J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
[TBL] [Abstract][Full Text] [Related]
39. Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder.
Azadzoi KM; Radisavljevic ZM; Siroky MB
Urology; 2008 May; 71(5):979-83. PubMed ID: 18314167
[TBL] [Abstract][Full Text] [Related]
40. Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
Simmons MA; Sobotka-Briner CD; Medd AM
Neuroscience; 2008 Oct; 156(4):987-94. PubMed ID: 18801417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
